Quantcast
U.S. FDA advisers recommend authorization of Merck's COVID-19 pill - Metro US

U.S. FDA advisers recommend authorization of Merck’s COVID-19 pill

FILE PHOTO: A handout photo of an experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP

(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday voted in favor of authorizing Merck & Co oral COVID-19 pill, saying the drug’s benefits outweigh its potential risks.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Lisa Shumaker)

More from our Sister Sites